نتایج جستجو برای: cml

تعداد نتایج: 6124  

Journal: :The Journal of clinical investigation 2016
Yanli Jin Jingfeng Zhou Fang Xu Bei Jin Lijing Cui Yun Wang Xin Du Juan Li Peng Li Ruibao Ren Jingxuan Pan

Imatinib-insensitive leukemia stem cells (LSCs) are believed to be responsible for resistance to BCR-ABL tyrosine kinase inhibitors and relapse of chronic myelogenous leukemia (CML). Identifying therapeutic targets to eradicate CML LSCs may be a strategy to cure CML. In the present study, we discovered a positive feedback loop between BCR-ABL and protein arginine methyltransferase 5 (PRMT5) in ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Michael Brave Vicki Goodman Edvardas Kaminskas Ann Farrell William Timmer Sarah Pope Ravi Harapanhalli Haleh Saber David Morse Julie Bullock Angela Men Carol Noory Roshni Ramchandani Leslie Kenna Brian Booth Joga Gobburu Xiaoping Jiang Rajeshwari Sridhara Robert Justice Richard Pazdur

PURPOSE On June 28, 2006, the U.S. Food and Drug Administration approved dasatinib (Sprycel; Bristol-Myers Squibb), a new small-molecule inhibitor of multiple tyrosine kinases, for the treatment of adults with chronic phase, accelerated phase, or myeloid or lymphoid blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+) ALL) with resis...

Journal: :Blood 2013
Loretta A Williams Araceli G Garcia Gonzalez Patricia Ault Tito R Mendoza Mary L Sailors Janet L Williams Furong Huang Aziz Nazha Hagop M Kantarjian Charles S Cleeland Jorge E Cortes

We developed a module of the MD Anderson Symptom Inventory (MDASI) for patients with chronic myeloid leukemia (CML). To develop the MDASI-CML, we identified CML-specific symptoms from qualitative interviews with 35 patients. A list of candidate symptoms was reduced by a panel of patients, caregivers, and clinicians to the 13 core MDASI symptom items and 6 CML-specific items; these items were su...

Journal: :Blood 1998
R Bhatia C M Verfaillie

Chronic myelogenous leukemia (CML) is characterized by the continuous proliferation and abnormal circulation of malignant hematopoietic progenitors. This may be related to the unresponsiveness of CML progenitors to beta1 integrin adhesion receptor-mediated inhibition of progenitor proliferation by the marrow microenvironment. In hematopoietic cell lines, the BCR-ABL oncogene product, p210(BCR-A...

Journal: :Remote Sensing 2021

The motivation for improving gridded precipitation data lies in weather now-casting and flood forecasting. Therefore, over the past decade, Commercial Microwave Link (CML) attenuation have been used to determine rain rates between microwave antennas, produce more accurate countrywide grids. CML networks offer a unique advantage measurements due their high density. However, these experience unce...

2017
Simona Salati Valentina Salvestrini Chiara Carretta Elena Genovese Sebastiano Rontauroli Roberta Zini Chiara Rossi Samantha Ruberti Elisa Bianchi Greta Barbieri Antonio Curti Fausto Castagnetti Gabriele Gugliotta Gianantonio Rosti Micaela Bergamaschi Agostino Tafuri Enrico Tagliafico Roberto Lemoli Rossella Manfredini

The development of Imatinib mesylate (IM), which targets the oncogenic BCR-ABL fusion protein, has greatly improved the outcome of Chronic Myeloid Leukemia (CML) patients. However, BCR-ABL-positive progenitors can be detected in CML patients in complete cytogenetic response. Several evidence suggests that CML stem cells are intrinsically resistant to Tyrosine Kinase Inhibitors (TKI), and theref...

Journal: :Journal of Clinical Biochemistry and Nutrition 2007
Khaled A. Ahmed Sekaran Muniandy Ikram S. Ismail

This study aims to determine the levels of N(epsilon)-(carboxymethyl)lysine (CML) in patients with Type 2 diabetic patients with and without ischemic heart disease (IHD) and to find for a possible association between circulating CML and a number of clinical parameters including lipids, hemoglobin A1c (HbA1c) and malondialdehyde (MDA) in Type 2 diabetic IHD patients. Serum CML levels were measur...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000
N Uesugi N Sakata R Nagai T Jono S Horiuchi S Takebayashi

BACKGROUND N(epsilon)-carboxymethyllysine (CML) is a product of the oxidative modification of glycated proteins, which damages proteins with ageing, diabetes, uraemia and Alzheimer's disease. In contrast, pyrraline is one of the advanced glycation end products, which is independent of oxidative processes. CML has been identified in beta-amyloid of Alzheimer's disease and beta(2)-microglobulin-a...

2016
Yanli Jin Yiwu Yao Li Chen Xiaohui Zhu Bei Jin Yingying Shen Juan Li Xin Du Yuhong Lu Sheng Jiang Jingxuan Pan

Quiescent leukemia stem cells (LSCs) that are insensitive to BCR-ABL tyrosine kinase inhibitors confer resistance to imatinib in chronic myelogenous leukemia (CML). Identifying proteins to regulate survival and stemness of LSCs is urgently needed. Although histone deacetylase inhibitors (HDACis) can eliminate quiescent LSCs in CML, little is known about the underlying mechanism that HDACis kill...

Journal: :Transplantation 1981
E Goulmy G Persijn E Blokland J D'Amaro J J van Rood

Cell-mediated lympholysis (CML) reactivity against the splenocytes of the kidney donor might be a good in vitro correlate of the homograft reaction. The present study was performed in an attempt to determine whether CML nonreactivity between unrelated donor-recipient combinations occur and, if so, under what conditions. We were able to show that CML nonreactivity occurs between unrelated donor-...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید